The longitudinal study of chronic sarcoidosis

Area of Science:

• Immunology
• Pulmonology
• Dermatology

Background:

• Sarcoidosis exhibits spontaneous remissions but can also lead to chronic, disabling disease.
• Disease severity and persistence appear more pronounced in Black patients.
• Extensive initial manifestations correlate with a higher likelihood of persistent sarcoidosis.

Purpose of the Study:

• To review the natural history and management of chronic sarcoidosis.
• To highlight factors influencing disease progression and treatment outcomes.
• To emphasize the importance of long-term patient management strategies.

Main Methods:

• Review of clinical observations regarding sarcoidosis progression and treatment.
• Analysis of factors affecting disease course, including patient demographics and treatment adherence.
• Evaluation of therapeutic responses to corticosteroids and chloroquine.

Main Results:

• Corticosteroids are generally effective with infrequent complications.
• Delayed or interrupted treatment can lead to disease progression or irreversible damage.
• Relapses are common upon treatment withdrawal but often reversible; low-dose daily prednisone may prevent them.
• Prolonged treatment (10-15+ years) is frequently necessary.
• Chloroquine is beneficial for cutaneous and mucosal sarcoidosis.

Conclusions:

• Effective management of chronic sarcoidosis requires long-term, individualized strategies.
• Patient compliance significantly impacts treatment success and disease control.
• A sustained, low-dose corticosteroid regimen and targeted therapies like chloroquine are vital for managing persistent sarcoidosis.